| 1 |
Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, Zhu W, Zhang J. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res 2023;42:65. [PMID: 36932427 DOI: 10.1186/s13046-023-02638-9] [Reference Citation Analysis]
|
| 2 |
Song S, Shi Y, Zeng D, Xu J, Yang Y, Guo W, Zheng Y, Tang H. circANKRD28 inhibits cisplatin resistance in non-small-cell lung cancer through the miR-221-3p/SOCS3 axis. J Gene Med 2023;:e3478. [PMID: 36740786 DOI: 10.1002/jgm.3478] [Reference Citation Analysis]
|
| 3 |
Yu X, Liu H, Chang N, Fu W, Guo Z, Wang Y. Circular RNAs: New players involved in the regulation of cognition and cognitive diseases. Front Neurosci 2023;17:1097878. [PMID: 36816112 DOI: 10.3389/fnins.2023.1097878] [Reference Citation Analysis]
|
| 4 |
Shi S, Wang T, Wang L, Wang M. Nomogram based on a circular RNA biomarker for predicting the likelihood of successful sperm retrieval via microdissection testicular sperm extraction in patients with idiopathic non-obstructive azoospermia. Front Endocrinol (Lausanne) 2022;13:1109807. [PMID: 36733803 DOI: 10.3389/fendo.2022.1109807] [Reference Citation Analysis]
|
| 5 |
Wang M, Zhang L, Chang W, Zhang Y. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes. Front Immunol 2022;13:1096551. [PMID: 36726985 DOI: 10.3389/fimmu.2022.1096551] [Reference Citation Analysis]
|
| 6 |
Wang X, Zhang C, Song H, Yuan J, Zhang L, He J. CircCCDC66: Emerging roles and potential clinical values in malignant tumors. Front Oncol 2022;12:1061007. [PMID: 36698408 DOI: 10.3389/fonc.2022.1061007] [Reference Citation Analysis]
|
| 7 |
Duan ZP, Yu XJ, Wei HL. Circular RNA Sec61 subunit alpha isoform 1 by competitive absorption of microRNA-513a-5p mediates peroxisomal biogenesis factor 5 expression and promotes the malignant phenotype of non-small cell lung cancer. Kaohsiung J Med Sci 2022. [PMID: 36567627 DOI: 10.1002/kjm2.12639] [Reference Citation Analysis]
|
| 8 |
Ao X, Liu Y. Novel insights into circular RNA regulation in arsenic-exposure-induced lung cancer. Molecular Therapy - Oncolytics 2022;27:200-202. [DOI: 10.1016/j.omto.2022.10.010] [Reference Citation Analysis]
|
| 9 |
Liu Y, Li X, Zhou X, Wang J, Ao X. FADD as a key molecular player in cancer progression. Mol Med 2022;28:132. [DOI: 10.1186/s10020-022-00560-y] [Reference Citation Analysis]
|
| 10 |
Wang Z, Wen Z, Xu H, Zhang Y, Zhang Y. Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.1004221] [Reference Citation Analysis]
|
| 11 |
Liu Y, Li Y, Du C, Kuang S, Zhou X, Zhang J, Ao X. Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression. J Mol Med (Berl) 2022;100:1539-56. [PMID: 36163376 DOI: 10.1007/s00109-022-02257-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Wang M, Zhang Y, Chang W, Zhang L, Syrigos KN, Li P. Noncoding RNA-mediated regulation of pyroptotic cell death in cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1015587] [Reference Citation Analysis]
|
| 13 |
Xie Z, Wang C, Li L, Chen X, Wei G, Chi Y, Liang Y, Lan L, Hong J, Li L. lncRNA-AC130710/miR-129-5p/mGluR1 axis promote migration and invasion by activating PKCα-MAPK signal pathway in melanoma. Open Med (Wars) 2022;17:1612-22. [PMID: 36329788 DOI: 10.1515/med-2022-0587] [Reference Citation Analysis]
|
| 14 |
Qi J, Yin J, Ding G, Cao S. A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9261339] [Reference Citation Analysis]
|
| 15 |
Ding W, Liu Y, Su Z, Li Q, Wang J, Gao Y. Emerging Role of Non-Coding RNAs in Aortic Dissection. Biomolecules 2022;12:1336. [DOI: 10.3390/biom12101336] [Reference Citation Analysis]
|
| 16 |
Luo W, Liu Y, Qu H, Luo X, Xu L, Zhang J, Wang J. CircKIF4A promotes non-small cell lung cancer proliferation and metastasis through MiR-1238/CLDN14 axis. Aging (Albany NY) 2022;14. [PMID: 36098705 DOI: 10.18632/aging.204276] [Reference Citation Analysis]
|
| 17 |
Zhou X, Ao X, Jia Z, Li Y, Kuang S, Du C, Zhang J, Wang J, Liu Y. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Front Oncol 2022;12:951864. [PMID: 36059609 DOI: 10.3389/fonc.2022.951864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Zhang L, Zhang Y, Yu F, Li X, Gao H, Li P. The circRNA-miRNA/RBP regulatory network in myocardial infarction. Front Pharmacol 2022;13:941123. [DOI: 10.3389/fphar.2022.941123] [Reference Citation Analysis]
|
| 19 |
Liu Y, Ao X, Jia Y, Li X, Wang Y, Wang J. The FOXO family of transcription factors: key molecular players in gastric cancer. J Mol Med (Berl) 2022;100:997-1015. [PMID: 35680690 DOI: 10.1007/s00109-022-02219-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Wang M, Chen X, Yu F, Zhang L, Zhang Y, Chang W. The Targeting of Noncoding RNAs by Quercetin in Cancer Prevention and Therapy. Oxid Med Cell Longev 2022;2022:4330681. [PMID: 35656022 DOI: 10.1155/2022/4330681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Liu Y, Wang Y, Li X, Jia Y, Wang J, Ao X. FOXO3a in cancer drug resistance. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215724] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 22 |
Yang F, Ao X, Ding L, Ye L, Zhang X, Yang L, Zhao Z, Wang J. Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications. Bioessays 2022;:e2100256. [PMID: 35355301 DOI: 10.1002/bies.202100256] [Reference Citation Analysis]
|
| 23 |
Yang SM, Lv S, Zhang W, Cui Y. Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges. Sensors (Basel) 2022;22:1620. [PMID: 35214519 DOI: 10.3390/s22041620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 24 |
Zhou Y, Tang W, Zhuo H, Zhu D, Rong D, Sun J, Song J. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. Bioengineered 2022;13:4786-97. [PMID: 35139763 DOI: 10.1080/21655979.2022.2032972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 25 |
Liu Y, Ao X, Wang Y, Li X, Wang J. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. Front Oncol 2022;12:841411. [DOI: 10.3389/fonc.2022.841411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 26 |
Liu Y, Ao X, Zhou X, Du C, Kuang S. The regulation of PBXs and their emerging role in cancer. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
|
